Issuance of Stock Options for Employees
First written in FY2017-Q1. 3 of 8 entries say "Softened", first in FY2018. Latest entry: FY2023-Q2.
- FY2023-Q2Stock option disclosure no longer reportedAnnual report
「(1) Details of the stock option plan: Not applicable. (2) Status of other stock acquisition rights, etc.: Not applicable. Reversal gain on stock acquisition rights: ¥1.213 million.」
For the employee stock options reported through the previous filing, the quarterly report issued after the end of the exercise period states that neither the stock option plan nor other stock acquisition rights are applicable, and records a ¥1.213 million reversal gain on stock acquisition rights. - FY2022RestatedAnnual report
「Eligible recipients and number of recipients: Employees, 309. Number of stock acquisition rights: 42. Class, description and number of shares underlying the stock acquisition rights: Common shares, 4,200. Exercise period: 29 September 2019 to 28 September 2022.」
The stock options granted to 309 employees had an unexercised balance of 4,200 shares, with the exercise period remaining from 29 September 2019 to 28 September 2022. - FY2021Substantial decline in unexercised balanceAnnual report
「Unexercised balance: 4,200」
The unvested balance of stock options granted to 309 employees declined from the previously reported 54,400 shares to 4,200 shares. The exercise period is from 29 September 2019 to 28 September 2022. - FY2019Decrease in unvested balanceAnnual report
「Eligible recipients and number of recipients: Employees, 309. Class, description and number of shares underlying the stock acquisition rights: Common shares, 54,400. Exercise period: 29 September 2019 to 28 September 2022.」
The unvested balance of stock options granted to 309 employees was 54,400 shares, down from 58,600 shares at the end of the previous fiscal year. - FY2018Decrease in unvested balanceAnnual report
「2016 Stock Options: Eligible recipients and number of recipients: Employees, 309. Number of stock acquisition rights: 586. Class, description and number of shares underlying the stock acquisition rights: Common shares, 58,600.」
The unvested balance of stock options granted to 309 employees was 58,600 shares, down from 60,800 shares at the end of the previous fiscal year. The exercise period is from 29 September 2019 to 28 September 2022. - FY2017RestatedAnnual report
「2016 Stock Options: Eligible recipients and number of recipients: Employees, 309. Unvested balance: 60,800 shares. Exercise period: 29 September 2019 to 28 September 2022.」
For stock options granted to 309 employees, 60,800 shares were reported as the unvested balance following the lapse of 1,000 shares, and the exercise period remains unchanged. - FY2017-Q2AdvancedAnnual report
「The stock acquisition rights issued during the second quarter accounting period are as follows: Number of stock acquisition rights: 618. Number of shares underlying the stock acquisition rights: 61,800. Exercise period: 29 September 2019 to 28 September 2022.」
For employee stock options, 618 stock acquisition rights representing 61,800 shares were issued during the second quarter accounting period. The exercise period is also specified. - FY2017-Q1First statedAnnual report
「At a meeting of the Board of Directors held on 29 July 2016, the Company resolved to issue the following stock acquisition rights to its employees as stock options. Eligible recipients and number of recipients: Company employees, 364. Number of stock acquisition rights to be issued: 728. Number of shares underlying the stock acquisition rights: 72,800. Exercise period: 29 September 2019 to 28 September 2022.」
As a significant subsequent event, the filing describes a resolution to issue 728 stock acquisition rights representing 72,800 shares to 364 employees. The exercise period is from 29 September 2019 to 28 September 2022.